| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |